- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00413465
Study of Renal Blood Flow During Human Endotoxemia
December 18, 2006 updated by: Rigshospitalet, Denmark
Renal Plasma Flow During Experimental Human Endotoxemia
The purpose of the present protocol is to study whether endotoxemia will affect the renal blood flow in type 2 diabetics and healthy volunteers.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Many septic patients develop acute renal failure and the risk is higher in patients with diabetes.
The pathogenetic mechanisms behind the development of acute renal failure in connection with sepsis is not completely understood.
One among many possible explanations is a change in renal hemodynamics.
However, it is still largely unknown what happens to the renal plasma flow during human sepsis.
In this study we give endotoxin injection (0,3 ng/kg) to type 2 diabetics and healthy controls as an experimental model of sepsis.
Renal plasma flow and glomerular filtration rate are measured by DTPA-renography 1 day before before and 1,25 and 6,5 hours after injection of endotoxin.
Furthermore WBC, plasma-cytokines,VCAM-1/ICAM-1, endothelin-1, Thromboxane B2, angiotensin 2, renin and PAI-1 are measured on an hourly basis up to 8 hours after endotoxin injection.
Study Type
Interventional
Enrollment
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Anne Sofie Andreasen, MD
- Phone Number: +45 3545 1616
- Email: sofie_andreasen@msn.com
Study Contact Backup
- Name: Bente K Pedersen, Professor
- Phone Number: +45 3545 7621
- Email: bkp@rh.dk
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Recruiting
- Intensiv Care Unit, Rigshospitalet,
-
Principal Investigator:
- Anne Sofie Andreasen, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy
- Type 2 diabetes
Exclusion Criteria:
- Renal failure
- Heart failure
- Lung disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Renal plasma flow, Glomerular filtration rate, Plasma cytokine content, Endotoxemia score, Plasma angiotensin II and renin content, Plasma thromboxane B2 content, Plasma PAI-1 content
|
Secondary Outcome Measures
Outcome Measure |
---|
Mean arterial pressure, Heart rate, Oxygen saturation, Body temperature,
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anne Sofie Andreasen, MD, Rigshospitalet, Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2006
Study Completion
December 1, 2007
Study Registration Dates
First Submitted
December 18, 2006
First Submitted That Met QC Criteria
December 18, 2006
First Posted (Estimate)
December 19, 2006
Study Record Updates
Last Update Posted (Estimate)
December 19, 2006
Last Update Submitted That Met QC Criteria
December 18, 2006
Last Verified
December 1, 2006
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RPF.sa.cim.rh.dk
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Escherichia Coli Endotoxin
-
University of Alabama at BirminghamAmerican Fibromyalgia Syndrome AssociationCompleted
-
University of California, Los AngelesCompletedInflammatory Response | Alcohol Use Disorder | Craving | Depressed MoodUnited States
-
Rigshospitalet, DenmarkCompletedHealthy | Type 2 Diabetes | EndotoxemiaDenmark
-
Radboud University Medical CenterUMC UtrechtCompletedSepsis, Endotoxemia, ImmunosuppressionNetherlands
-
Medical University of ViennaCompletedHealthy Subjects | Imparied Retinal Vascular ReactivityAustria
-
Herlev HospitalUnknown
-
GlaxoSmithKlineBiomedical Advanced Research and Development AuthorityTerminatedHealthy VolunteersGermany
-
University of AarhusCompletedMetabolic Diseases | Inflammation | Febrile Illness AcuteDenmark
-
Medical University of ViennaCompletedRetina | Regional Blood Flow | Endotoxin, Escherichia ColiAustria